Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-006902
Filing Date
2013-02-06
Accepted
2013-02-06 19:29:18
Documents
1
Period of Report
2013-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 13386
  Complete submission text file 0001209191-13-006902.txt   14684
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Issuer) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address
Jaen Juan C. (Reporting) CIK: 0001422996 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35420 | Film No.: 13579697